266 related articles for article (PubMed ID: 23814167)
1. Increased skeletal muscle-specific microRNA in the blood of patients with COPD.
Donaldson A; Natanek SA; Lewis A; Man WD; Hopkinson NS; Polkey MI; Kemp PR
Thorax; 2013 Dec; 68(12):1140-9. PubMed ID: 23814167
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
[TBL] [Abstract][Full Text] [Related]
3. Differences in micro-RNA expression profile between vastus lateralis samples and myotubes in COPD cachexia.
Barreiro E; Sancho-Muñoz A; Puig-Vilanova E; Salazar-Degracia A; Pascual-Guardia S; Casadevall C; Gea J
J Appl Physiol (1985); 2019 Feb; 126(2):403-412. PubMed ID: 30543501
[TBL] [Abstract][Full Text] [Related]
4. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD.
Puig-Vilanova E; Martínez-Llorens J; Ausin P; Roca J; Gea J; Barreiro E
Clin Sci (Lond); 2015 Jun; 128(12):905-21. PubMed ID: 25628226
[TBL] [Abstract][Full Text] [Related]
5. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.
Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I
Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641
[TBL] [Abstract][Full Text] [Related]
6. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?
Puig-Vilanova E; Ausin P; Martinez-Llorens J; Gea J; Barreiro E
PLoS One; 2014; 9(7):e102296. PubMed ID: 25013984
[TBL] [Abstract][Full Text] [Related]
7. Different Training-Induced Skeletal Muscle Adaptations in COPD Patients with and without Alpha-1 Antitrypsin Deficiency.
Jarosch I; Gehlert S; Jacko D; Koczulla RA; Wencker M; Welte T; Bloch W; Janciauskiene S; Kenn K
Respiration; 2016; 92(5):339-347. PubMed ID: 27686000
[TBL] [Abstract][Full Text] [Related]
8. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD.
van den Borst B; Slot IG; Hellwig VA; Vosse BA; Kelders MC; Barreiro E; Schols AM; Gosker HR
J Appl Physiol (1985); 2013 May; 114(9):1319-28. PubMed ID: 22815389
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD.
Lewis A; Riddoch-Contreras J; Natanek SA; Donaldson A; Man WD; Moxham J; Hopkinson NS; Polkey MI; Kemp PR
Thorax; 2012 Jan; 67(1):26-34. PubMed ID: 21998125
[TBL] [Abstract][Full Text] [Related]
10. Quadriceps miR-542-3p and -5p are elevated in COPD and reduce function by inhibiting ribosomal and protein synthesis.
Farre-Garros R; Lee JY; Natanek SA; Connolly M; Sayer AA; Patel H; Cooper C; Polkey MI; Kemp PR
J Appl Physiol (1985); 2019 Jun; 126(6):1514-1524. PubMed ID: 30676868
[TBL] [Abstract][Full Text] [Related]
11. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis.
Gosker HR; Zeegers MP; Wouters EF; Schols AM
Thorax; 2007 Nov; 62(11):944-9. PubMed ID: 17526675
[TBL] [Abstract][Full Text] [Related]
12. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.
Kharbanda S; Ramakrishna A; Krishnan S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1727-35. PubMed ID: 26366065
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of quadriceps weakness in COPD and the relationship with disease severity.
Seymour JM; Spruit MA; Hopkinson NS; Natanek SA; Man WD; Jackson A; Gosker HR; Schols AM; Moxham J; Polkey MI; Wouters EF
Eur Respir J; 2010 Jul; 36(1):81-8. PubMed ID: 19897554
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance is associated with skeletal muscle weakness in COPD.
Wells CE; Polkey MI; Baker EH
Respirology; 2016 May; 21(4):689-96. PubMed ID: 26678022
[TBL] [Abstract][Full Text] [Related]
16. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease.
Couillard A; Maltais F; Saey D; Debigaré R; Michaud A; Koechlin C; LeBlanc P; Préfaut C
Am J Respir Crit Care Med; 2003 Jun; 167(12):1664-9. PubMed ID: 12672647
[TBL] [Abstract][Full Text] [Related]
17. miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss.
Paul R; Lee J; Donaldson AV; Connolly M; Sharif M; Natanek SA; Rosendahl U; Polkey MI; Griffiths M; Kemp PR
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):119-128. PubMed ID: 28984049
[TBL] [Abstract][Full Text] [Related]
18. Circulating miRNAs from imprinted genomic regions are associated with peripheral muscle strength in COPD patients.
Lee JY; Donaldson AV; Lewis A; Natanek SA; Polkey MI; Kemp PR
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446557
[No Abstract] [Full Text] [Related]
19. Quadriceps muscle strength in scoliosis.
Swallow EB; Barreiro E; Gosker H; Sathyapala SA; Sanchez F; Hopkinson NS; Moxham J; Schols A; Gea J; Polkey MI;
Eur Respir J; 2009 Dec; 34(6):1429-35. PubMed ID: 19443534
[TBL] [Abstract][Full Text] [Related]
20. Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD.
Natanek SA; Gosker HR; Slot IG; Marsh GS; Hopkinson NS; Moxham J; Kemp PR; Schols AM; Polkey MI
Eur Respir J; 2013 Jun; 41(6):1275-83. PubMed ID: 23258787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
